Review of selenium and prostate cancer prevention

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2181-2184

  Yang, Lei ^a   Pascal, Mouracade ^b   Wu, Xiao Hou ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Clinical trials; Prevention; Prostate cancer; Selenium

Indexed keywords

EID: 84880263391     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2181     Document Type: Short Survey

References (20)

1. Clark LC, Combs GF, Turnbull BW, et al (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276, 1957-63
2. Clark LC, Dalkin B, Krongrad A, et al (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81, 730-4.
3. Diwadkar-Navsariwala V, Prins GS, Swanson SM, et al (2006). Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A, 103, 8179-84.
4. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int, 91, 608-12.
5. Grundmark B, Zethelius B, Garmo H, et al (2011). Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer, 11, 431.
6. Hsing AW, Chokkalingam AP(2006). Prostate cancer epidemiology. Front Biosci, 11, 1388-413.
7. Hu JC, Gu X, Lipsitz SR, et al (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302, 1557-64.
8. Hurst R, Hooper L, Norat T, et al (2012). Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr, 96, 111-22.
9. Lippman SM, Goodman PJ, Klein EA, et al (2005). Designing the selenium and vitamin E cancer prevention trial (SELECT). J Natl Cancer Inst, 97, 94-102.
10. Lippman SM, Klein EA, Goodman PJ, et al (2009). Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA, 301, 39-51.
11. Marshall JR, Tangen CM, Sakr WA, et al (2011). Phase III trial of selenium to prevent [rostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila), 4, 1761-9.
12. Ozten N, Horton L, Lasano S, et al (2010). Selenomethionine and -tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model. Cancer Prev Res (Phila), 3, 371-80.
13. Rayman MP(2000). The importance of selenium to human health. Lancet, 356, 233-41.
14. Sabichi AL, Lee JJ, Taylor RJ, et al (2006). Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group study. Clin Cancer Res, 12, 2178-84.
15. Sanda MG, Dunn RL, Michalski J, et al (2008). Quality of life and satisfaction with outcome among prostate cancer survivors. N Engl J Med, 358, 1250-61.
16. Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.
17. Silberstein JL, Parsons JK (2010). Prostate cancer prevention: concepts and clinical recommendations. Prostate Cancer Prostatic Dis, 13, 300-6.
18. Ware JH, Zhou Z, Kopelovich L, et al (2006). Evaluation of cancer chemopreventive agents using clones derived from a human prostate cancer cell line. Anticancer Res, 26, 4177-83.
19. Zhang J, Wang L, Li G, et al (2011). Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutr Cancer, 63, 778-89.
20. Zhang Y, Skolarus TA, Miller DC, et al (2011). Understanding prostate cancer spending growth among medicare beneficiaries. Urology, 77, 326-31